Literature DB >> 22017683

Novel computational approaches to polypharmacology as a means to define responses to individual drugs.

Lei Xie1, Li Xie, Sarah L Kinnings, Philip E Bourne.   

Abstract

Polypharmacology, which focuses on designing therapeutics to target multiple receptors, has emerged as a new paradigm in drug discovery. Polypharmacological effects are an attribute of most, if not all, drug molecules. The efficacy and toxicity of drugs, whether designed as single- or multitarget therapeutics, result from complex interactions between pharmacodynamic, pharmacokinetic, genetic, epigenetic, and environmental factors. Ultimately, to predict a drug response phenotype, it is necessary to understand the change in information flow through cellular networks resulting from dynamic drug-target interactions and the impact that this has on the complete biological system. Although such is a future objective, we review recent progress and challenges in computational techniques that enable the prediction and analysis of in vitro and in vivo drug-response phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017683     DOI: 10.1146/annurev-pharmtox-010611-134630

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  79 in total

Review 1.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

2.  Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.

Authors:  Xiaomeng Xu; Shifan Ma; Zhiwei Feng; Guanxing Hu; Lirong Wang; Xiang-Qun Xie
Journal:  J Mol Graph Model       Date:  2016-08-08       Impact factor: 2.518

Review 3.  Understanding resistance to combination chemotherapy.

Authors:  Justin R Pritchard; Douglas A Lauffenburger; Michael T Hemann
Journal:  Drug Resist Updat       Date:  2012-11-17       Impact factor: 18.500

4.  FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment.

Authors:  Haisu Ma; Hongyu Zhao
Journal:  Bioinformatics       Date:  2012-08-24       Impact factor: 6.937

5.  How promiscuous are pharmaceutically relevant compounds? A data-driven assessment.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  AAPS J       Date:  2012-10-23       Impact factor: 4.009

6.  What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  AAPS J       Date:  2013-04-19       Impact factor: 4.009

7.  Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.

Authors:  Zheng Zhao; Li Xie; Lei Xie; Philip E Bourne
Journal:  J Med Chem       Date:  2016-03-17       Impact factor: 7.446

8.  Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence.

Authors:  Shannan J Ho Sui; Raymond Lo; Aalton R Fernandes; Mackenzie D G Caulfield; Joshua A Lerman; Lei Xie; Philip E Bourne; David L Baillie; Fiona S L Brinkman
Journal:  Int J Antimicrob Agents       Date:  2012-07-20       Impact factor: 5.283

Review 9.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

10.  Drug-target interaction prediction by integrating chemical, genomic, functional and pharmacological data.

Authors:  Fan Yang; Jinbo Xu; Jianyang Zeng
Journal:  Pac Symp Biocomput       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.